Bioavailability and Bioequivalence study, BCS is a scientific framework for classifying drug substances based on their aqueous solubility and intestinal permeability.
It is a drug development tool that allows estimation of solubility, dissolution and intestinal permeability affect that oral drug absorption.
Plasma Drug Concentration Time Profile
Pharmacokinetic Parameter
Pharmacodynamic Parameter
Zero, First Order & Mixed Order Kinetic
Rates & Order Of Kinetics
Pharmacokinetic Models
Application Of Pharmacokinetic
CLINICAL SIGNIFICANCE OF BIOEQUIVALENCE STUDIES, BIOEQUIVALENCE, REASONS TO PERFORM BIOEQUIVALENCE STUDIES , NEED FOR BIOEQUIVALENCE STUDIES, IMPORTANCE OF BIOEQUIVALANCE STUDIES, DETERMINATION OF BIOEQUIVALENCE OF A DRUG PRODUCT, CLINICAL SIGNIFICANCE.
Plasma Drug Concentration Time Profile
Pharmacokinetic Parameter
Pharmacodynamic Parameter
Zero, First Order & Mixed Order Kinetic
Rates & Order Of Kinetics
Pharmacokinetic Models
Application Of Pharmacokinetic
CLINICAL SIGNIFICANCE OF BIOEQUIVALENCE STUDIES, BIOEQUIVALENCE, REASONS TO PERFORM BIOEQUIVALENCE STUDIES , NEED FOR BIOEQUIVALENCE STUDIES, IMPORTANCE OF BIOEQUIVALANCE STUDIES, DETERMINATION OF BIOEQUIVALENCE OF A DRUG PRODUCT, CLINICAL SIGNIFICANCE.
It is defined as “the predictive mathematical model that describes the relationship between in vitro property (such as rate & extent of dissolution) of a dosage form and in vivo response (such as plasma drug concentration or amount of drug absorbed)”.
It includes Introductory part about what is Dissolution...then Mechanism of Dissolution is elaborated...Theories of Dissolution also given..It also includes Factors affecting Dissolution profile..Along with References given below for easily searching..
Gastrointestinal tract, Mechanism of drug absorption, Factors
affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex.
Special concerns in bioavaliblity and bioeqvivalencePradnya Shirude
you will get here special concerns about bioavailability and bioequivalance. it will also give regulations and criteria for bioavalablity and bioeuivalance
Raft Forming System - Gastroretentive drug delivery systemIJAEMSJORNAL
In the recent times several studies and research have been conducted on drug delivery system through mouth in order to overcome several problems like emptying time and gastric retention. Taking medication through mouth is the preferable way compared to others, because of easiness in taking medication and compliance of patients. Limited gastric residence time is the limitation of taking medication orally. In order to increase this gastric retention time, several methods have been proposed. This article focuses on floating drug delivery system to overcome the difficulties associated with design of formulation. Advances and highlights of the floating raft system has been reviewed in this article. Formulation, mechanism, and development of raft forming system is also reviewed in this article.
Dissolution and In Vitro In Vivo Correlation (IVIVC)Jaspreet Guraya
This presentation gives a bird's eye view on Dissolution in context with IVIVC. It discusses various levels of Correlations currently in practice. IVIVC are explained in light of biowaivers It also touches upon IVIVR, IVIVM etc.
Factors affecting sustained release drug delivery system.Kavya S
contented and precise , Drug delivery system , sustained release preparation.factors like absorption, distribution ,metabolism , therapeutic window , absorption window.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
It is defined as “the predictive mathematical model that describes the relationship between in vitro property (such as rate & extent of dissolution) of a dosage form and in vivo response (such as plasma drug concentration or amount of drug absorbed)”.
It includes Introductory part about what is Dissolution...then Mechanism of Dissolution is elaborated...Theories of Dissolution also given..It also includes Factors affecting Dissolution profile..Along with References given below for easily searching..
Gastrointestinal tract, Mechanism of drug absorption, Factors
affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex.
Special concerns in bioavaliblity and bioeqvivalencePradnya Shirude
you will get here special concerns about bioavailability and bioequivalance. it will also give regulations and criteria for bioavalablity and bioeuivalance
Raft Forming System - Gastroretentive drug delivery systemIJAEMSJORNAL
In the recent times several studies and research have been conducted on drug delivery system through mouth in order to overcome several problems like emptying time and gastric retention. Taking medication through mouth is the preferable way compared to others, because of easiness in taking medication and compliance of patients. Limited gastric residence time is the limitation of taking medication orally. In order to increase this gastric retention time, several methods have been proposed. This article focuses on floating drug delivery system to overcome the difficulties associated with design of formulation. Advances and highlights of the floating raft system has been reviewed in this article. Formulation, mechanism, and development of raft forming system is also reviewed in this article.
Dissolution and In Vitro In Vivo Correlation (IVIVC)Jaspreet Guraya
This presentation gives a bird's eye view on Dissolution in context with IVIVC. It discusses various levels of Correlations currently in practice. IVIVC are explained in light of biowaivers It also touches upon IVIVR, IVIVM etc.
Factors affecting sustained release drug delivery system.Kavya S
contented and precise , Drug delivery system , sustained release preparation.factors like absorption, distribution ,metabolism , therapeutic window , absorption window.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
It contain the Per oral administration of drug ,
movement of drug through the GI Tract ; and according to that BCS Classification with BIOWAIVER Application.
biopharmaceuticals classification system and biowaiverRavish Yadav
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Pharmacy presentation about BCS classification its criteria.Biowaiever and its conditions .permeability studies in vivo,invitro,in situ.mpharmacy b pharmacy pharmaceutics
Biopharmaceutical classification system & drug delivery system associated wit...PratikShinde120
Biopharmaceutical classification system & drug delivery system based on BCS.
By Pratik shinde, Mpharm, University department of pharmaceutical sciences, Nagpur
BCS Guideline for solubility and Dissolution.pptxImdad H. Mukeri
Briefly explanation of The Biopharmaceutics Classification System (BCS) of drug substance
and its solubility in the pH range of 1–7.5, absorption or intestinal membrane permeability
In this presentation I have mentioned whatever the possible relevant content/guidelines require for biowaiver application.
Citation Is done at the end of slide.
Content is up to date & true to my belief.
Thanks & Best Regards.
Anurag Pandey
B.Pharm (FACULTY OF PHARMACY, INVERTIS UNIVERSITY)
M.Pharm (INSTITUTE OF PHARMACY, NIRMA UNIVERSITY)
Email :- anurag.dmk05@gmail.com
Biopharmaceutics classification system class 1Aloysiatreslyn
Biopharmaceutics classification system class
defination,bcs,class1 drugs,physiochemical parameters,advantages,disadvantages,list of drugs,formulaton consideration,solubility,permability,disssolution etc .The Biopharmaceutics Classification System is a system to differentiate the drugs on the basis of their solubility and permeability. This system restricts the prediction using the parameters solubility and intestinal permeability.
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsRam Kanth
Greetings!
Good Day to all...
Topic: Methods of Enhancing Bioavailability
Several approaches discussed are
1. Micrnoization
2. Use of Surrfactants
3. Use of Salt forms
4. Alteration of pH of microenvironment
5. Use of metastable polymorphs
6. Solute-Solvent Complexation
7. Solvent Deposition
8. Selective Adsorption on Insoluble Carriers
9. Solid Solutions
10. Eutectic Mixtures
11. Solid Dispersions
12. Molecular Encapsulation with Cyclodextrins
Please do clarify for doubts if any....
Thank you all for watching this presentation.
Compression : It is reduction in bulk volume of the material as a result of displacement of gaseous phase (entrapped air). When external force is applied to powder mass there is reduction in bulk volume. The onset of loading is associated with closed repacking of a powder mass followed by deformation.
Sustained Released Ophthalmic FormulationMcpl Moshi
Dr. V. S. Kashikar
Ophthalmic drug delivery is one of the most challenging endeavor facing the pharmaceutical scientists. The anatomy, physiology and biochemistry of the eye render this organ highly impervious to foreign substance.
Rapid and efficient drainage by the nasolacrimal apparatus, noncorneal absorption and the relative impermeability of the cornea to both hydrophilic and hydrophobic molecules, all account for such poor ocular bioavailability. Thus to increase the ocular bioavailability of drug, we need to increase the ocular residence time of the drug.
Quality audit is defined as a systematic and independent examination to determine whether activities and related results comply with planned arrangements and whether these arrangements are implemented effectively and are suitable to achieve objectives Quality audit means a systematic examination of a quality system
Quality audits are typically performed at defined intervals
.Definition
Objectives
Difference between Quality audit and Periodic evaluation
Self inspection
Types of Quality Audit
Role OF GMP Audit in QA and QC programmes
Elements of a Systemic Audit program
Dr. V. S. Kashikar
QUALITY CONTROL OF TABLETS IPQC stands for in process quality control. These are checks that are carried out before the manufacturing process is completed.
Career Guidance to First Year B. Pharm studentsMcpl Moshi
Career Guidance to First Year B. Pharm students
Induction Program
More recently, pharmacists have been faced with increasing health demands which change their direction and focus to PATIENTS instead of the Product.
Bioavailability and bioequivalence studyMcpl Moshi
BCS is a scientific framework for classifying drug substances based on their aqueous solubility and intestinal permeability.
It is a drug development tool that allows estimation of solubility, dissolution and intestinal permeability affect that oral drug absorption.
Kashikar V S
PES Modern College of Pharmacy ( for ladies), Moshi Pune
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
2. Biopharmaceutics Classification System
BCS is a scientific framework for classifying drug
substances based on their aqueous solubility and
intestinal permeability.
It is a drug development tool that allows estimation of
solubility, dissolution and intestinal permeability affect
that oral drug absorption.
Key parameters are characterized in BCS classification
are :
1. Absorption number (An)
2. Dissociation number (Dn)
3. Dose number (Do)
2
3. Absorption No. (An) :- It is the ratio of Residence time
(Tres) to Mean absorbance time (Tabs)
An ˃ 1 → indicate Complete absorption
Dissolution No. (Dn) :- The time required for drug
dissolution which is the ratio of intestinal residence time
to the dissolution time.
Higher the Dn → Higher fraction dose absorbed.
Dose No. (Do):- It is the ratio of dose concentration to
drug solubility.
Do ≤ 1→ higher solubility.
Do ˃ 1→ low solubility.
3
4. Class Boundaries
HIGHLY SOLUBLE:- The highest dose strength should be soluble in <
250 ml water over a pH range of 1 to 7.5.
Acc. To BCS the highest dose strength volume in 250 ml, where the D/S
ratio <250 refer to highly soluble But it s not true for pediatric patient
HIGHLY PERMEABLE:- When the extent of absorption in humans is
determined to be > 90% of an administered dose.
Based on mass balance or compared with an iv route.
RAPIDLY DISSOLVING :- When > 85% of the labeled amount of drug
substance dissolves within 30 minutes using USP apparatus I or II in a
volume of < 900 ml buffer solutions
This study is important for biological and in vivo-in vitro
correalation.(IVIVC).
4
6. Biowaiver
The term Biowaiver is applied to a regulatory drug approval process
when the drug dossier (application) is approved based on the evidence
of equivalence other than through in vivo equivalence testing.
In 1995 the American Department of Health & Human Service US
Food & Drug Administration (HHS-FDA) instigated the
Biopharmaceutics Classification System (BCS), with the aim of
granting so-called biowaivers for SUPACs.
BCS provides biowaivers for Class I, II, III drugs with some
specification.
As the BCS is only applicable to APIs which are absorbed from the
small intestine.
6
7. A Biowaiver means that in vivo bioavailability
and/or bioequivalence studies may be waived
(i.e. not considered necessary for product approval).
Bioavailability :- It means the rate and extent to which
the active drug substance is absorbed from a
pharmaceutical dosage form and becomes available at
the site of action.
Bioequivalence :-It refers to the drug substance in two or
more identical dosage forms, reaches in systemic
circulation at the same rate and to the same relative
extent.
7
8. Biowaiver for Bioequivalence study
If two product, containing the same , have the same
concentration time profile at the intestinal membrane
surface then they will have the same rate and extent of
the absorption.
8
Generic Product Innovator Product / Std
recommended by USFDA
Ex. Paracetamol Tablet 650
mg
DOLO-650 mg
API - Paracetamol API - Paracetamol
Tablet (oral) Tablet (oral)
Bioavailability 80 % Bioavailability 80 %
9. Need & Objective for BE studies
If a new product is intended to be a substitute
for an approved medicinal product as a
pharmaceutical equivalent or alternative, the
equivalence with this product should be shown
or justified.
In order to ensure clinical performance of such
drug products, bioequivalence studies should be
performed.
9
11. In vitro BE studies
In vitro studies, i.e. dissolution studies can be used
instead of in vivo bioequivalence under certain
circumstances, called as biowaiver .
For waiver of in vivo, bioequivalence test and reference
product should exhibit similar dissolution profile under
the dissolution test condition defined for rapidly
dissolving product.
Two dissolution profile may be considered similar.
When both test and the reference products dissolve 85 %
or more of the labeled amount in less than 15 minutes in
all three dissolution media (at acidic i.e 01.N HCL, at
pH 4.5 buffer and at 6.8 buffer ). A profile comparison
is unnecessary.
11
12. Techniques For Improving Bioavailability
One approach to improve the systemic availability of the
drug is to deliver it by alternative routes of
administration such as parenteral, nasal, vaginal, rectal
or transdermal. However, improvement of the oral
bioavailability of the drug is the most realistic approach,
as it is the most preferred and convenient route of
administration.
The techniques to improve oral bioavailability of the
drugs are described as follows:
12
13. Enhancement Of Drug Solubility Or
Dissolution Rate
1. Micronization
2. Nanonization
3. Supercritical Fluid Re-crystalization
4. Spray Freezing into Liquid (SFL)
5. Evaporative Precipitation into Aqueous Solution
(EPSA)
6. Use of Surfactants
7. Use of Salt Forms
8. Use of Precipitation Inhibitors
9. Alteration of pH of the Drug Microenvironment
10. Use of Amorphous, Anhydrates, Solvates and
Metastable polymorphs
13
15. Micronization :-
The process involves reducing the size of the solid
particles to 1 to 10 microns commonly by spray drying
or by use of air attrition methods. This process is also
called as mico-milling.
Nanonisation :-
It is a process of the dry powder is converted to
nanocrystals of sizes 200-600 nm . Eg. Amphotericin B.
i. Pearl milling
ii. Homogenisation in water
iii. Homogenisation in non-aqueous media.
15
16. Spray Freezing into Liquid (SFL) :-
This technique involves an aqueous, organic, aqueous-
organic cosolvent solution, aqueous organic emulsion
and suspension containing drug and pharmaceutical
excipients (CO2, helium, propane, ethane).
The frozen particles are then lyophilized to obtain dry
and free-flowing micronized powders.
SFL powder containing amorphous nanostructured
aggregates with high surface area and excellent
wettability.
16
17. Solvent Deposition :-
In this method, the poorly aqueous soluble drug such as
nifedipine is dissolved in an organic solvent like alcohol
and deposited on an inert, hydrophilic, solid matrix such
as starch or MCC by evaporation of solvent.
17
18. Solid Dispersions :
These are generally prepared by Solvent or co-
precipitation method whereby both the guest solute and
the solid carrier solvent are dissolved in a common
volatile liquid solvent such as alcohol.
The liquid solvent is removed by evaporation under
reduced pressure or by freeze drying which results in
amorphous precipitation of guest in a crystalline carrier.
These method is suitable for thermolabile substances.
18
19. Enhancement Of Drug Permeability
Across Biomembrane
1. Lipid technology :
With an increase in the number of emerging
hydrophobic drugs, several lipid –based formulations
have been designed to improve their bioavailability.
2. Ion pairing :
The ion pairing approach involves co-administration of a
hydrophilic or polar with a suitable lipophilic
counterion, which consequently improves the
partitioning of the resultant ion-pair into the intestinal
membrane.
These technique use to improve the oral BA of ionisable
drugs. Eg ; Atenolol
19
20. 3. Penetration Enhancers :
Compound which facilitate the transport of drugs across
the biomembrane are called penetration / permeation
enhancer or promoters.
This method is used mainly in cases of hydrophilic
drugs which are expected to have difficulty in
penetrating the lipid structure of the biomembrane.
Eg. of Penetration enhancers :-
Citric acid, SLS, EDTA, Salicylates and fatty acids such
as oleic acid linoleic acid arachidonic acid.
20
21. Enhancement of Drug Stability
1. Enteric coating :
Enteric-coated systems utilize polymeric coatings that
are insoluble in the gastric media and therefore, prevent
or retard drug release in the stomach. Such systems
release the drug in the alkaline media in intestine.
Eg. Erythromycin, penicilin v, benzimidazole,
omeprazol can be improved by enteric coating.
2. Complexation :
It can be used to increase the stability of drug in GI
media. Generally Beta- cyclodextrins are potential
carriers for increasing the oral bioavailability of
caffeiene, sodium salicylate, sodium benzoate.
21
22. 3. Use of Metabolic inhibiters :
Co-administration of drug (with low BA) and its
metabolism, which can selectively inhibit any of the
contributing processes, would result in increased
fractional absorption and hence increases bioavailability.
22
23. Significance of Biowaiver
It can save both time and money—if the immediate -
release, orally administered drug meets specific criteria,
the FDA will grant a waiver for expensive and time-
consuming bioequivalence studies.
Valuable tool for formulation scientist for selection of
design of formulated drug substance.
When integrated with other information provide a
tremendous tool for efficient drug development.
Reduces cost and time of approving Scale- up and post
approval challenges.
Applicable in both pre-clinical and clinical drug
development process.
23
24. Reference
1. Shekhawat P, Pokharkar V, Understanding peroral
absorption: regulatory aspects and contemporary approaches
to tackling solubility and permeability hurdles, Review
Article, Acta Pharmaceutica Sinica B, 2017, Volume 7, Page
no. 260-280.
2. Dahan A, Miller J, Amidon G , Prediction of Solubility and
Permeability Class Membership: Provisional BCS
Classification of the World’s Top Oral Drugs , Review
Article , American Association of Pharmaceutical Scientists,
2009 , Volume 11, Page no.740 - 746.
3. Chavda H, Patel C, Anand I, Biopharmaceutics
Classification System, Review Article , Sys Rev Pharm,
2010, Volume 1, Page no. 62-69.
24
25. 4. Valsami G, Macheras P, Computational-Regulatory Developments
in the Prediction of Oral Drug Absorption, Review Article , Wiley
VCH Verlag GmbH & Co. KGaA, Weinheim , 2011, Page no. 112-
121.
5. Murakami T, Absorption sites of orally administered drugs in the
small intestine, Review Article, Informa UK Limited, trading as
Taylor & Francis Group, 2017
25